Skip to main content
OpenTrials
Completed

NCT Number: NCT00756093

Acute Comfort and Blurring Profile Evaluation of Marketed Lubricant Eye Drops

To evaluate drop comfort, acceptability and blur profile between four marketed artificial tears in dry eye patients

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Alcon Call Center

Fort Worth, Texas, 76134, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • documented diagnosis of dry eye

Exclusion criteria

  • use of topical ocular drops within 2 hours preceding enrollment

Treatment and study plan

Systane Ultra Lubricant Eye Drops

Other

Systane Ultra Lubricant Eye Drops one drop each eye one time

Optive lubricant Eye Drops

Other

Optive Lubricant Eye Drops one drop each eye one time

Blink Tears

Other

Blink Tears one drop each eye one time

GenTeal Moderate Lubricant Eye Drops

Other

GenTeal Moderate Lubricant Eye Drops one drop each eye one time

Primary outcomes

  1. Drop Comfort

    Time frame: once upon instillation

    Drop comfort grading scale is a 0 to 9 scale, with 0 meaning most comfortable and 9 meaning most uncomfortable.

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Sep 19, 2008
Registry last updated
Feb 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.